Sponsor:
National Cancer Institute (NCI)
Code:
NCT05361811
Conditions
Neurofibromatosis 1
Noonan Syndrome
Legius Syndrome
Cardiofaciocutaneous Syndrome
Costello Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Waitlist
ACT Intervention
Brief summary:
Conditions
Neurofibromatosis 1
Noonan Syndrome
Legius Syndrome
Cardiofaciocutaneous Syndrome
Costello Syndrome
Study ID
NCT05361811
Start date
Jan 10, 2024
Status verified date
Aug 20, 2026
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Jun 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
70 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: 1/Internal Pilot
active comparator: 2/Immediate Intervention
active comparator: 3/Waitlist Control
Interventions
Waitlist
ACT Intervention
Primary outcome measure
Central contacts
Locations
National Cancer Institute (NCI)
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
Sponsor
National Cancer Institute (NCI)
Last update posted
Aug 24, 2026
Last verified
Aug 20, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2026-08-24.